Company intelligence / Profile preview

Asacpharma

Alicante, Alicante, Spainlaboratoriosapi.com ↗

Ownership: Private
Employees: ~400
Development stage: Commercial

Overview

Asac Pharmaceutical Immunology is a fully commercial-stage company producing allergenic and bacterial immunotherapy products, including allergenic extracts for diagnosis and hyposensitization, as well as bacterial vaccines and autovaccines. All products are manufactured under EU GMP and EMA guidelines. The company has a presence in multiple countries and a history of international exports but does not appear to sponsor advanced global clinical trials of novel molecular entities.

Therapeutic areas: ImmunologyInfectious Diseases
Modalities: VaccineBiologicBacterial vaccineAllergenic extract
Industry: Biotech

Drug pipeline

1 asset

Cadelius D

Unknown

Partnerships

Distribution agreements in Portugal and Latin AmericaAcademic collaborations (R&D with universities)

Beyond the preview

Go deeper on Asacpharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Asacpharma.

Explore the full profile